# Tranexamic Acid During Colonic Endoscopic Resection Procedures

> **NCT05345613** · PHASE4 · RECRUITING · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Colon Neoplasm

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Standard

## Key facts

- **NCT ID:** NCT05345613
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345613, "Tranexamic Acid During Colonic Endoscopic Resection Procedures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05345613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*